Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem bolus infusion for ventilator-associated pneumonia with augmented renal clearance
IRCT20260201068728N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of meropenem in ventilator-associated pneumonia (VAP) and augmented renal clearance (ARC), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Feb 2026; status: completed.
02
Drugs
meropenem
03
Conditions
ventilator-associated pneumonia (VAP)augmented renal clearance (ARC)
Beyond the preview
Go deeper on IRCT20260201068728N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260201068728N1.